Advanced-nuclear-reactor startup TerraPower is getting clearance from the Nuclear Regulatory Commission (NRC) to build a nuclear power plant in Kemmerer, Wyoming. This is the first commercial-scale ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...

Data work in 2026 asks for more than chart building. Professionals are expected to clean data, query databases, explain trends, and present findings clearly across business, finance, product, and ...

From the world’s first in-reactor thorium breeding confirmation to a dual PWR-HTGR plant and commercial supercritical CO₂ generation, China is assembling a vertically integrated advanced nuclear ...

As one of Europe’s established specialist conferences in the field of electrochemical energy storage, Advanced Battery Power focuses on the entire battery value chain, ranging from materials research ...

Feb 10 (Reuters) - Microsoft is exploring using superconducting ‌power lines in its data centers, ‌which could potentially accelerate its massive U.S. build-out of the server warehouses by making them ...

Rei Penber is the Deputy Lead Editor for GameRant's Anime and Manga team, originally from Kashmir and currently based in Beirut. He brings seven years of professional experience as a writer and editor ...

That 5 percent? They’re gaining an extra day and a half of productivity every single week. The other 95 percent are stuck using AI for basic search and document summarization, essentially treating a ...

What new nuclear technologies mean for safety, costs, and more. Nuclear power continues to be one of the hottest topics in energy today, and in our recent online Roundtables discussion about ...

Pennsylvanians should pay close attention to how corporate power and political influence are converging around the rapid expansion of data centers across our state. With deep ties to federal ...

NORTH CHICAGO, Ill. and YANTAI, China, Jan. 12, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) and RemeGen today announced an exclusive licensing agreement for the development, manufacturing and ...